EarliTec Diagnostics, Inc.
Developer of an FDA-cleared, tablet-based eye-tracking assessment system that captures moment-by-moment visual-attention biomarkers to support clinicians in early evaluation and monitoring of autism in young children. Combines academic research, large-scale clinical validation, regulatory authorization, and provider partnerships to produce objective, repeatable metrics for diagnostic assessment and outcome tracking.
Industries
N/A
Products
Tablet-based eye-tracking evaluation system for pediatric autism assessment
A clinician-use tablet system that captures gaze behavior while a child views standardized video stimuli, analyzes visual-attention biomarkers, and produces standardized reports to aid diagnostic assessment and track outcomes over time.
Tablet-based eye-tracking evaluation system for pediatric autism assessment
A clinician-use tablet system that captures gaze behavior while a child views standardized video stimuli, analyzes visual-attention biomarkers, and produces standardized reports to aid diagnostic assessment and track outcomes over time.
Services
Provider network access and site qualification
Program to qualify clinical sites for low-cost access to the assessment system and to connect families with participating evaluation locations.
Webinars and on-demand clinician education
Educational webinar series and on-demand content for clinicians and providers, including recorded sessions accessible after live events and optional CEU credits through third-party platforms.
Provider network access and site qualification
Program to qualify clinical sites for low-cost access to the assessment system and to connect families with participating evaluation locations.
Webinars and on-demand clinician education
Educational webinar series and on-demand content for clinicians and providers, including recorded sessions accessible after live events and optional CEU credits through third-party platforms.
Expertise Areas
- Early autism assessment and monitoring
- Eye-tracking biomarker development
- Clinical validation and trial evidence generation
- Regulatory submissions and FDA authorization
Key Technologies
- Tablet-based eye-tracking
- Social visual-attention biomarkers
- High-frequency gaze sampling (~120 Hz)
- Explainable machine learning